We also analyzed the correlation of TXNIP expression and the selected clinicopathological factors in liver (Additional file 8: Table S3), lung (Additional file 8: Table S4), and breast cancer (Additional file 8: Table S5), and finally observed distinct conclusions concerning these tumors. Here, TXNIP is linked to breast cancer.